Halozyme share price
WebGet Halozyme Therapeutics Inc (HALO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. WebHistorical daily share price chart and data for Halozyme Therapeutics since 2024 adjusted for splits. The latest closing stock price for Halozyme Therapeutics as of April 06, 2024 is 38.33.. The all-time high Halozyme Therapeutics stock closing price was 59.44 on December 02, 2024.; The Halozyme Therapeutics 52-week high stock price is 59.46, …
Halozyme share price
Did you know?
WebGet the latest Halozyme Therapeutics, Inc. (HALO) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … WebShare Price. as of April 5 4:00:00 PM EST. Halozyme Therapeutics Company Stats. Industry Drugs & Biotechnology. Founded 1998. Headquarters San Diego, California. Country …
WebMar 17, 2024 · The consensus estimate for Halozyme Therapeutics' current full-year earnings is $2.56 per share. SVB Leerink also issued estimates for Halozyme Therapeutics' Q1 2024 earnings at $0.78 EPS, Q2 2024 earnings at $0.90 EPS, Q3 2024 earnings at $0.94 EPS and Q4 2024 earnings at $0.92 EPS. Several other research firms also … WebGet Halozyme Therapeutics Inc (HALO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
WebHalozyme Therapeutics Inc (HALO) Common Stock USD0.001. Halozyme Therapeutics Inc (HALO) Sell: $32.18 Buy: $38.36 $0.88 (2.36%) Market closed Prices as at close on 31 March 2024 Turn off ... Web18 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Halozyme Therapeutics (HALO)
WebApr 13, 2024 · Under the terms of the merger agreement, Halozyme will commence a cash tender offer to acquire all of the outstanding shares of Antares for $5.60 per share in cash. The transaction is not subject ...
WebApr 13, 2024 · The company has a market cap of $4.92 billion, a price-to-earnings ratio of 25.06, a price-to-earnings-growth ratio of 0.57 and a beta of 1.22. Halozyme Therapeutics, Inc. has a 12-month low of $32.83 and a 12-month high of $59.46. The company has a quick ratio of 4.88, a current ratio of 5.65 and a debt-to-equity ratio of 8.79. brickbattle guyWebApr 6, 2024 · The average twelve-month price prediction for Halozyme Therapeutics is $56.33 with a high price target of $68.00 and a low price target of $42.00. Learn more on … brick batteryWebFeb 26, 2024 · The signified lack of projected business resulted in a salient downturn, with HALO opening price on January 10th valuing at $55.7, and concluding at $50.56. Since then, stock valuation has ... brick battlefieldWebHalozyme Therapeutics, Inc. (HALO) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 38.33 +0.90 (+2.40%) At close: 04:00PM EDT. 38.63 +0.30 … Find the latest Halozyme Therapeutics, Inc. (HALO) stock discussion in Yahoo … Halozyme Therapeutics, Inc. 12390 El Camino Real San Diego, CA 92130 … Find out all the key statistics for Halozyme Therapeutics, Inc. (HALO), including … See Halozyme Therapeutics, Inc. (HALO) stock analyst estimates, including … Interactive Chart for Halozyme Therapeutics, Inc. (HALO), analyze all … Discover historical prices for HALO stock on Yahoo Finance. View daily, weekly or … View the basic HALO option chain and compare options of Halozyme … See Halozyme Therapeutics, Inc. (HALO) Environment, Social and Governance … Find out the direct holders, institutional holders and mutual fund holders for … Find the latest Halozyme Therapeutics, Inc. (HALO) stock quote, history, news and … brick battle.comWebHalozyme Therapeutics (HALO) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Support: 888-992-3836 Home NewsWire Subscriptions ... Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned - $ -- brickbattle codesWebApr 4, 2024 · HALOZYME THERAPEUTICS, INC. : Trading strategies, financial analysis, commentaries and investment guidance for HALOZYME THERAPEUTICS, INC. Stock Nasdaq: HALO Nasdaq brick battle hack scriptWebApr 13, 2024 · SVB Leerink downgraded shares of Halozyme Therapeutics from an “outperform” rating to a “market perform” rating and set a $42.00 price target on the stock. in a report on Thursday, March 16th. brick battleplate set